Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Deciphex decodes $2.6m
Based at DCU Invent, Deciphex has gained investors including Inova and GI Partners as it looks to refine its offering for the toxicologic and gastrointestinal segments of pathology.
Oxford Brain Diagnostics secures funding
Oxford Brain Diagnostics hopes to commercialise an early diagnosis tool for Alzheimer’s disease pioneered through eight years of University of Oxford research.
Mind Foundry discerns Parkwalk funding
The follow-on investment complements $1.7m raised by Oxford data analytics spinout Mind Foundry in 2016 from investors including Oxford Sciences Innovation.
Think-Lands needles $3m
Building on Chiba and Hokkaido university research, Think-Lands is aiming to commercialise microneedles manufactured with its optical vortex production system.
Happe Spine erects funding round
Based on research at University of Notre Dame, Happe Spine is working on implants for interbody spinal fusion.
Energetic Insurance jumps at $2.5m opportunity
Congruent Ventures has led a $2.5m funding round for Energetic Insurance, which hopes to enable SMEs to tap into the solar energy market.
Nanology Labs finds Facit for funding
The Toronto oncological MRI agent spinout has been backed by Facit’s Prospects Oncology vehicle, to target applications including the identification and treatment of tumours in the brain.
Mallinda takes temperature for $2m
Sabic has equipped Mallinda with funding as the CU Boulder-founded thermoset resins provider gears up for the launch of its first commercial product.

Other News

Avectas collects $10m
NUI Maynooth spinout Avectas has added capital to converted equity previously supplied by therapeutics developer Adapt Pharma among others.
TearSolutions eyes $6.4m
UVA’s seed fund and corporate venturing unit PharmStandard Ventures featured in topical dry eye syndrome peptide spinout TearSolutions' financing round, taking its total to $21.5m.
Liopa gets more than lip service in seed round
Queen’s University Belfast speech recognition technology spinout Liopa is working on a product that analyses lip movements to provide more robust analysis in noisy environments.
Oxford Genetics locks in $8.5m
Founding investor Mercia Technologies joined fund manager Invesco for the synthetic biology contractor’s latest round, taking its total funding past the $25m mark.
Starts at 60 relishes $1.9m
QUT Bluebox has joined corporates Holland Insurance and Seven West Media in the second funding round for over-60s package holiday portal Starts at 60.
Sana Biotechnology manoeuvres from Harvard
Sana has emerged with funding from investors including F-Prime Capital, Arch and Flagship Pioneering to develop genetically modified hypoimmogenic stem cells.

Editor's Picks

Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
University Ventures looks to online future
Higher education investment fund University Ventures is to invest in its own startup.
MOOCs: The British are coming
Futurelearn, a platform free-to-access Massive Open Online Courses (MOOCs), has been launched by a consortium of UK-based universities, led by distance-learning provider The Open University (OU).
Cell Medica raises $26.5m
Invesco Perpetual, the fund manager, and Imperial Innovations, the London Stock Exchange-listed spin-off from Imperial College London, are joined by The Cancer Prevention and Research Institute of Texas and the Wellcome Trust supporting Cell Medica's growth.
test reg